NO985325L - Anvendelse av substituert azaspiran ved behandling av astma - Google Patents
Anvendelse av substituert azaspiran ved behandling av astmaInfo
- Publication number
- NO985325L NO985325L NO985325A NO985325A NO985325L NO 985325 L NO985325 L NO 985325L NO 985325 A NO985325 A NO 985325A NO 985325 A NO985325 A NO 985325A NO 985325 L NO985325 L NO 985325L
- Authority
- NO
- Norway
- Prior art keywords
- azaspiran
- substituted
- asthma
- treatment
- administering
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1788996P | 1996-05-17 | 1996-05-17 | |
PCT/IB1997/000688 WO1997044030A1 (en) | 1996-05-17 | 1997-05-15 | Use of substituted azaspirane in the treatment of asthma |
Publications (2)
Publication Number | Publication Date |
---|---|
NO985325D0 NO985325D0 (no) | 1998-11-16 |
NO985325L true NO985325L (no) | 1998-11-16 |
Family
ID=21785110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO985325A NO985325L (no) | 1996-05-17 | 1998-11-16 | Anvendelse av substituert azaspiran ved behandling av astma |
Country Status (17)
Country | Link |
---|---|
US (1) | US6025364A (cs) |
EP (1) | EP0910373A1 (cs) |
JP (1) | JP2000513335A (cs) |
KR (1) | KR20000010933A (cs) |
CN (1) | CN1219129A (cs) |
AU (1) | AU710542B2 (cs) |
BR (1) | BR9709007A (cs) |
CA (1) | CA2253217A1 (cs) |
CZ (1) | CZ367598A3 (cs) |
HU (1) | HUP0003908A3 (cs) |
IL (1) | IL127040A0 (cs) |
NO (1) | NO985325L (cs) |
NZ (1) | NZ332627A (cs) |
PL (1) | PL329931A1 (cs) |
SK (1) | SK156698A3 (cs) |
WO (1) | WO1997044030A1 (cs) |
ZA (1) | ZA974271B (cs) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2518357A1 (en) * | 2003-03-10 | 2004-09-23 | Callisto Pharmaceuticals, Inc. | Method of treating cancer with azaspirane compositions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963557A (en) * | 1987-09-28 | 1990-10-16 | Smithkline Beecham Corporation | Immunomodulatory azaspiranes |
AU652583B2 (en) * | 1990-09-24 | 1994-09-01 | Smithkline Beecham Corporation | Methods |
ZA921120B (en) * | 1991-02-19 | 1993-01-27 | Smithkline Beecham Corp | Cytokine inhibitors |
US5482959A (en) * | 1992-01-28 | 1996-01-09 | Smithkline Beecham Corporation | Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds |
GB9315306D0 (en) * | 1993-07-23 | 1993-09-08 | Smithkline Beecham Corp | Methods |
GB9315340D0 (en) * | 1993-07-23 | 1993-09-08 | Smithkline Beecham Corp | Methods |
GB9315351D0 (en) * | 1993-07-23 | 1993-09-08 | Smithkline Beecham Corp | Methods |
-
1997
- 1997-05-15 PL PL97329931A patent/PL329931A1/xx unknown
- 1997-05-15 AU AU29739/97A patent/AU710542B2/en not_active Ceased
- 1997-05-15 BR BR9709007-7A patent/BR9709007A/pt not_active Application Discontinuation
- 1997-05-15 HU HU0003908A patent/HUP0003908A3/hu unknown
- 1997-05-15 CA CA002253217A patent/CA2253217A1/en not_active Abandoned
- 1997-05-15 EP EP97924183A patent/EP0910373A1/en not_active Withdrawn
- 1997-05-15 NZ NZ332627A patent/NZ332627A/en unknown
- 1997-05-15 IL IL12704097A patent/IL127040A0/xx unknown
- 1997-05-15 US US09/180,843 patent/US6025364A/en not_active Expired - Fee Related
- 1997-05-15 CZ CZ983675A patent/CZ367598A3/cs unknown
- 1997-05-15 JP JP09541943A patent/JP2000513335A/ja active Pending
- 1997-05-15 WO PCT/IB1997/000688 patent/WO1997044030A1/en not_active Application Discontinuation
- 1997-05-15 SK SK1566-98A patent/SK156698A3/sk unknown
- 1997-05-15 CN CN97194664A patent/CN1219129A/zh active Pending
- 1997-05-15 KR KR1019980709081A patent/KR20000010933A/ko not_active Withdrawn
- 1997-05-16 ZA ZA974271A patent/ZA974271B/xx unknown
-
1998
- 1998-11-16 NO NO985325A patent/NO985325L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0910373A1 (en) | 1999-04-28 |
NZ332627A (en) | 2001-06-29 |
CA2253217A1 (en) | 1997-11-27 |
KR20000010933A (ko) | 2000-02-25 |
AU710542B2 (en) | 1999-09-23 |
NO985325D0 (no) | 1998-11-16 |
HUP0003908A2 (en) | 2001-03-28 |
HUP0003908A3 (en) | 2001-04-28 |
CZ367598A3 (cs) | 1999-05-12 |
SK156698A3 (en) | 1999-06-11 |
CN1219129A (zh) | 1999-06-09 |
PL329931A1 (en) | 1999-04-26 |
AU2973997A (en) | 1997-12-09 |
JP2000513335A (ja) | 2000-10-10 |
IL127040A0 (en) | 1999-09-22 |
BR9709007A (pt) | 2000-01-04 |
WO1997044030A1 (en) | 1997-11-27 |
ZA974271B (en) | 1998-08-25 |
US6025364A (en) | 2000-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1555025A3 (en) | Use of dehydroepiandrosterone analogs for the treatment of asthma | |
FI965123A7 (fi) | Yhdisteitä ja menetelmiä sydänverisuonitautien, tulehdustautien ja immuunihäiriöiden hoitamiseksi | |
IL130931A0 (en) | Small molecules useful in the treatment of inflammatory disease | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
ES2166110T3 (es) | Agonistas no alostericos de gabaa para tratar trastornos del sueño. | |
EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
ITRM920412A1 (it) | Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico. | |
NO991619L (no) | Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper | |
DE69729004D1 (de) | Photodynamische therapie zur behandlung von osteosrthritis | |
IT1290781B1 (it) | Agente attivo terapeutico per il trattamento di malattie degenerative neuronali. | |
DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
SE9600120D0 (sv) | Novel medical use | |
NO985325L (no) | Anvendelse av substituert azaspiran ved behandling av astma | |
NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
ID27052A (id) | Pengobatan arthritis dan keadaan-keadaan lain yang sekupa | |
TR199801801T2 (xx) | Madde k�t�ye kullan�m�n�n tedavisi. | |
NO990436L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
FI950649A7 (fi) | Substituoidut sykloheksanoliesterit, niiden käyttö sairauksien hoitamiseksi ja farmaseuttiset valmisteet | |
NO984190L (no) | FremgangsmÕte for behandling av insomnia | |
EA199800698A1 (ru) | Способ лечения и фармацевтическая композиция | |
EA199800820A1 (ru) | Способ лечения злоупотребления лекарственными средствами | |
UA25164A (uk) | Спосіб оперативhого лікуваhhя косоокості по в.і. ємчеhку | |
UA25165A (uk) | Спосіб оперативhого лікуваhhя косоокості по в.і. ємчеhку |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |